article thumbnail

STAT+: A new list ranks large pharmaceutical companies by research and development

STAT

If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. That’s the message from the 12th edition of the Pharmaceutical Innovation and Invention Index, produced by the consultancy Idea Pharma, which was released Thursday at the STAT Breakthrough Summit.

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Discover the leading patient adherence pharmaceutical companies. Pharmaceutical Technology has listed the top patient adherence pharmaceutical companies based on our intel, insights and decades-long expertise in the sector. Patient adherence.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Innoviva enters agreement to acquire La Jolla Pharmaceutical Company

Pharmaceutical Technology

Innoviva has signed a definitive merger agreement for the acquisition of all of the outstanding shares of La Jolla Pharmaceutical Company for $6.23 The post Innoviva enters agreement to acquire La Jolla Pharmaceutical Company appeared first on Pharmaceutical Technology.

article thumbnail

Pressure is building on pharma and biotech companies to take climate action

STAT

As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business.

article thumbnail

STAT+: Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts

STAT

At the same time, Coherus will sell its drug at a discount to the Mark Cuban Cost Plus Drug Company, which will market the treatment for about $579. The lowball pricing for the drug, which will become available in July, has the potential to alter one of the most closely watched product rollouts by pharmaceutical companies in many years.

article thumbnail

A Win for Indiana Patients: “Share the Savings” Legislation Now Law

PhRMA

Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM.

article thumbnail

Artificial Intelligence is Changing the Face of Pharmacovigilance

Pharmacy Times

Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.